Predict your next investment

HEALTHCARE | Medical Devices & Equipment
bionessinc.com

See what CB Insights has to offer

Stage

Acquired | Acquired

Total Raised

$3.5M

Valuation

$0000 

About Bioness

Bioness offers medical devices designed to benefit people with stroke, Multiple Sclerosis, traumatic brain injury, Cerebral Palsy, and spinal cord injury. These products use electrical stimulation to help people regain mobility and independence, to improve quality of life and productivity.On March 31st, 2021, Bioness was acquired by Bioventus at a valuation between $45M and $110M.

Bioness Headquarter Location

25103 Rye Canyon Loop

Valencia, California, 91355,

United States

661-362-4850

Latest Bioness News

Bioventus sees overall growth in third quarter compared with 2020

Dec 4, 2021

Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Please try again later. If you continue to have this issue please contact customerservice@slackinc.com . Back to Healio Bioventus Inc. reported $108.9 million in net sales for the third quarter of 2021 vs. its reported $85.9 million for the third quarter of 2020, according to a company press release. The company attributed the 26.8% net sales increase to acquisitions, strong commercial execution and ongoing recovery from the COVID-19 pandemic. International net sales for the company also showed an increase of 38.5% (34.7% on a constant currency basis) for the third quarter. Gross profit was $79.1 million vs. $62.5 million for the third quarter of 2020. Non- generally accepted accounting principles (GAAP) gross profit was $85.7 million, an increase of 26.1% vs. 2020, and non-GAAP operating income was $15.1 million, up by 2.3% vs. 2020. Non-GAAP net income was $13.8 million vs. $12.6 million for the third quarter of 2020. However, adjusted earnings before interest, taxes, depreciation, and amortization decreased from $23.1 million in 2020 to $21.3 million for the third quarter. Operating loss was $1 million vs. an operating income of $6.9 million for the third quarter of 2020. Net loss was $2.3 million vs. a net income of $8 million in 2020. “During the third quarter, we continued building momentum across our diversified portfolio as the Bioventus team demonstrated strong execution and resiliency, driving double-digit organic growth despite some pandemic related headwinds in our Bone Graft Substitutes business,” Ken Reali, CEO of Bioventus, said in the release. “We are on-track to complete the integration of Bioness in the first quarter of 2022 and deliver on our cost synergy targets over the course of the next year.” Read more about

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Bioness

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Bioness is included in 1 Expert Collection, including Medical Devices.

M

Medical Devices

10,972 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

Bioness Patents

Bioness has filed 53 patents.

The 3 most popular patent topics include:

  • Neurological disorders
  • Neurotrauma
  • Electrotherapy
patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/10/2018

8/3/2021

Neurotrauma, Neurophysiology, Lower limb anatomy, Electrotherapy, Neurotechnology

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

7/10/2018

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

8/3/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Neurotrauma, Neurophysiology, Lower limb anatomy, Electrotherapy, Neurotechnology

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.